WordNet

relating to or having the characteristics of a family; "children of the same familial background"; "familial aggregation"
occurring among members of a family usually by heredity; "an inherited disease"; "familial traits"; "genetically transmitted features" (同)genetic, hereditary, inherited, transmitted, transmissible
type genus of the family Cancridae (同)genus Cancer
the fourth sign of the zodiac; the sun is in this sign from about June 21 to July 22 (同)Cancer the Crab, Crab
(astrology) a person who is born while the sun is in Cancer (同)Crab
a small zodiacal constellation in the northern hemisphere; between Leo and Gemini
any malignant growth or tumor caused by abnormal and uncontrolled cell division; it may spread to other parts of the body through the lymphatic system or the blood stream (同)malignant neoplastic disease
relating to the prostate gland (同)prostatic

PrepTutorEJDIC

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

Prevalence of incidental prostate cancer: A systematic review of autopsy studies.

Bell KJ1,2, Del Mar C1, Wright G3, Dickinson J4,5, Glasziou P1.
International journal of cancer. Journal international du cancer.Int J Cancer.2015 Oct 1;137(7):1749-57. doi: 10.1002/ijc.29538. Epub 2015 Apr 21.
Prostate cancer screening may detect nonprogressive cancers, leading to overdiagnosis and overtreatment. The potential for overdiagnosis can be assessed from the reservoir of prostate cancer in autopsy studies that report incidental prostate cancer rates in men who died of other causes. We aimed to
PMID 25821151

Clinical perspectives: Practical insights from clinical experience with cabazitaxel in Australia.

Parente P1,2, Gurney H3, Ng S4, Bahre M4.
Asia-Pacific journal of clinical oncology.Asia Pac J Clin Oncol.2015 Sep;11(3):199-207. doi: 10.1111/ajco.12343. Epub 2015 Apr 9.
Prostate cancer, and in particular the management options for patients with metastatic castration-resistant prostate cancer (mCRPC), remains an important health issue. The approval of cabazitaxel provides a new treatment option for patients who have progressed despite docetaxel therapy. Clinical use
PMID 25856659

Increased risk of additional cancers among patients with gastrointestinal stromal tumors: A population-based study.

Murphy JD1, Ma GL2,3, Baumgartner JM2, Madlensky L4, Burgoyne AM5, Tang CM2, Martinez ME4, Sicklick JK2.
Cancer.Cancer.2015 Sep 1;121(17):2960-7. doi: 10.1002/cncr.29434. Epub 2015 Apr 30.
BACKGROUND: Most gastrointestinal stromal tumors (GISTs) are considered nonhereditary or sporadic. However, single-institution studies suggest that GIST patients develop additional malignancies at increased frequencies. It was hypothesized that greater insight could be gained into possible associati
PMID 25930983